Answers are grounded in this paper and cite their sources.
Case report highlights recurrent stroke in a woman with cancer and heparin-induced thrombocytopenia, complicating treatment decisions.
We present the case of a 74-year-old woman with a large ovarian tumor who developed cancer-associated stroke with multiple acute cerebral infarcts and markedly elevated D-dimer levels. Unfractionated heparin was initiated. However, thrombocytopenia and rising D-dimer levels on Day 11 led to its discontinuation and a diagnosis of probable heparin-induced thrombocytopenia, supported by a strongly positive PF4/heparin antibody assay. Despite subsequent non-heparin anticoagulation, she developed recurrent ischemic stroke and systemic embolic events, and surgery for the ovarian tumor was no longer feasible. This case highlights the therapeutic dilemma posed by the coexistence of cancer-associated stroke and immune-mediated heparin-induced thrombocytopenia.
No takes yet. Share an insight, caveat, or question.
Okada et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: